MAYO CLINIC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia
Phase 1
Completed
- Conditions
- B-cell Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic LeukemiaStage 0 Chronic Lymphocytic LeukemiaStage I Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic Leukemia
- Interventions
- Biological: alemtuzumabBiological: rituximabDrug: PGG beta-glucanOther: flow cytometryOther: laboratory biomarker analysisGenetic: DNA analysisGenetic: fluorescence in situ hybridizationGenetic: polymerase chain reactionGenetic: polymorphism analysisGenetic: mutation analysis
- First Posted Date
- 2011-01-04
- Last Posted Date
- 2020-06-23
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 22
- Registration Number
- NCT01269385
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Microvesicle Production After Acute Trauma and Its Clinical Impact on Venothromboembolism
Completed
- Conditions
- Venothromboembolism
- First Posted Date
- 2010-12-21
- Last Posted Date
- 2021-04-08
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 1234
- Registration Number
- NCT01264458
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
A Comparison of Infection Rates Between Two Surgical Sites
Completed
- Conditions
- Corneal ToxicityOtotoxicitySurgical Site Infection
- First Posted Date
- 2010-12-20
- Last Posted Date
- 2013-10-24
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 600
- Registration Number
- NCT01263262
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Phase 2
Completed
- Conditions
- Adult Nasal Type Extranodal NK/T-cell LymphomaRecurrent Adult Burkitt LymphomaRecurrent Adult Lymphoblastic LymphomaRecurrent Adult T-cell Leukemia/LymphomaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Grade 3 Follicular LymphomaSplenic Marginal Zone LymphomaWaldenstrom MacroglobulinemiaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma
- Interventions
- Other: laboratory biomarker analysisGenetic: western blottingGenetic: DNA analysisOther: flow cytometryOther: pharmacological studyOther: immunohistochemistry staining method
- First Posted Date
- 2010-12-16
- Last Posted Date
- 2022-05-24
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 41
- Registration Number
- NCT01261247
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
Effect of Cannabinoid Agonist on Gastrointestinal and Colonic Motor Functions in Patients With Irritable Bowel Syndrome (IBS)
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2013-05-07
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 36
- Registration Number
- NCT01253408
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Exercise for Fibromyalgia
Not Applicable
Completed
- Conditions
- Fibromyalgia
- Interventions
- Behavioral: Strength trainingBehavioral: Aerobic exercise
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2010-12-03
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 72
- Registration Number
- NCT01253395
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Carbon-13 (13C)-Spirulina Platensis Gastric Emptying Breath Test (GEBT)
Not Applicable
Completed
- Conditions
- Dyspepsia
- Interventions
- Drug: [13C]-Spirulina platensis and 99mTc sulfur colloid
- First Posted Date
- 2010-11-25
- Last Posted Date
- 2013-03-18
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 30
- Registration Number
- NCT01248221
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Assessment of Combined Bowel Preparation for Capsule Endoscopy Study
Phase 1
Completed
- Conditions
- Gastrointestinal Hemorrhage
- Interventions
- Drug: Combination Prep
- First Posted Date
- 2010-11-18
- Last Posted Date
- 2016-01-20
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 50
- Registration Number
- NCT01243736
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Self Help Intervention to Decrease Stress
Not Applicable
Completed
- Conditions
- Stress, Psychological
- Interventions
- Behavioral: Attention and Interpretation Therapy
- First Posted Date
- 2010-11-17
- Last Posted Date
- 2013-04-26
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 33
- Registration Number
- NCT01242865
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Vitamin D Supplementation in Breastfeeding Women
Phase 2
Completed
- Conditions
- RicketsVitamin D DeficiencyInfant Nutrition Disorders
- Interventions
- Dietary Supplement: Vitamin D3
- First Posted Date
- 2010-11-15
- Last Posted Date
- 2013-04-30
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 80
- Registration Number
- NCT01240265
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath